 |
In May 2023 Avacta completed the acquisition of Belgian diagnostics business Coris BioConcept, which specialises in developing, manufacturing and marketing rapid diagnostic kits for the detection of human respiratory, gastro-enteric and blood-borne pathogens (bacteria, viruses and parasites) and for the detection of antibiotic resistance markers (RESIST range). These tests are based on the lateral flow immunochromatography technology with colloidal gold particles or latex microspheres and are CE marked for professional use.
Coris, which is ISO13485 certified, also provides services for custom test development and contract manufacturing. The company, which was founded in 1996, is present in more than 80 countries in Europe, Asia, South America, Africa and Oceania.
Visit the Coris website > |